|
Atomistry » Chlorine » PDB 5hi6-5hq4 » 5hm0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 5hi6-5hq4 » 5hm0 » |
Chlorine in PDB 5hm0: Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3Protein crystallography data
The structure of Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3, PDB code: 5hm0
was solved by
H.Jayaram,
F.Poy,
J.W.Setser,
S.F.Bellon,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3
(pdb code 5hm0). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3, PDB code: 5hm0: Chlorine binding site 1 out of 1 in 5hm0Go back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3
![]() Mono view ![]() Stereo pair view
Reference:
B.K.Albrecht,
V.S.Gehling,
M.C.Hewitt,
R.G.Vaswani,
A.Cote,
Y.Leblanc,
C.G.Nasveschuk,
S.Bellon,
L.Bergeron,
R.Campbell,
N.Cantone,
M.R.Cooper,
R.T.Cummings,
H.Jayaram,
S.Joshi,
J.A.Mertz,
A.Neiss,
E.Normant,
M.O'meara,
E.Pardo,
F.Poy,
P.Sandy,
J.Supko,
R.J.Sims,
J.C.Harmange,
A.M.Taylor,
J.E.Audia.
Identification of A Benzoisoxazoloazepine Inhibitor (Cpi-0610) of the Bromodomain and Extra-Terminal (Bet) Family As A Candidate For Human Clinical Trials. J.Med.Chem. V. 59 1330 2016.
Page generated: Sat Jul 12 02:49:45 2025
ISSN: ISSN 0022-2623 PubMed: 26815195 DOI: 10.1021/ACS.JMEDCHEM.5B01882 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |